Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness.
Eaton
H J
HJ
Phillips
P J
PJ
Hanieh
A
A
Cooper
J
J
Bolt
J
J
Torpy
D J
DJ
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D017273:Goserelin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010899:Pituitary Apoplexy / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin